EVO Evotec SE
Healthcare$2.91-3.96%ClosedMarket Cap: $1.03B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
1.28
P/S
1.20
EV/EBITDA
-14.32
DCF Value
$-3.53
FCF Yield
-4.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
11.5%
Operating Margin
-13.9%
Net Margin
-26.0%
ROE
-24.5%
ROA
-11.8%
ROIC
-7.9%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $159.2M | -1.0% | $-56.3M | $-123.9M | $— | — |
| Q4 null | $250.9M | 31.0% | $24.1M | $14.5M | $— | — |
| FY null | $757.3M | 8.3% | $-135.3M | $-99.4M | $— | — |
| Q3 null | $163.9M | -0.0% | $-44.5M | $-43.1M | $— | — |
| Q2 null | $171.2M | 5.0% | $-27.8M | $-43.5M | $— | — |
| Q1 null | $200.0M | 13.6% | $-20.0M | $-31.6M | $— | — |
| Q4 null | $221.2M | 20.8% | $6.8M | $-40.8M | $— | — |
| FY null | $797.0M | 14.4% | $-142.5M | $-196.1M | $— | — |
| Q3 null | $184.9M | 9.9% | $-26.5M | $-39.6M | $— | — |
| Q2 null | $182.1M | 8.6% | $-104.6M | $-94.9M | $— | — |
| Q1 null | $208.7M | 16.7% | $-18.2M | $-20.7M | $— | — |
| Q4 2023 | $201.3M | 18.7% | $-11.5M | $-16.1M | $-0.05 | — |